REGENXBIO, Inc. (RGNX)
8.06
-2.66
(-24.81%)
USD |
NASDAQ |
Aug 24, 16:00
8.08
+0.02
(+0.25%)
After-Hours: 20:00
REGENXBIO Market Cap : 436.56M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 580.64M |
| August 20, 2026 | 599.05M |
| August 19, 2026 | 651.05M |
| August 18, 2026 | 599.60M |
| August 17, 2026 | 613.68M |
| August 14, 2026 | 583.08M |
| August 13, 2026 | 577.39M |
| August 12, 2026 | 590.93M |
| August 11, 2026 | 576.85M |
| August 10, 2026 | 564.39M |
| August 07, 2026 | 580.64M |
| August 06, 2026 | 610.97M |
| August 05, 2026 | 568.72M |
| August 04, 2026 | 557.89M |
| August 03, 2026 | 514.11M |
| July 31, 2026 | 500.17M |
| July 30, 2026 | 522.36M |
| July 29, 2026 | 496.56M |
| July 28, 2026 | 495.52M |
| July 27, 2026 | 501.20M |
| July 24, 2026 | 502.23M |
| July 23, 2026 | 529.07M |
| July 22, 2026 | 526.49M |
| July 21, 2026 | 533.72M |
| July 20, 2026 | 532.69M |
| Date | Value |
|---|---|
| July 17, 2026 | 510.49M |
| July 16, 2026 | 578.11M |
| July 15, 2026 | 633.34M |
| July 14, 2026 | 634.37M |
| July 13, 2026 | 658.12M |
| July 10, 2026 | 720.06M |
| July 09, 2026 | 807.81M |
| July 08, 2026 | 786.13M |
| July 07, 2026 | 775.29M |
| July 06, 2026 | 765.48M |
| July 02, 2026 | 685.47M |
| July 01, 2026 | 675.67M |
| June 30, 2026 | 618.37M |
| June 29, 2026 | 610.63M |
| June 26, 2026 | 540.95M |
| June 25, 2026 | 528.56M |
| June 24, 2026 | 514.62M |
| June 23, 2026 | 513.59M |
| June 22, 2026 | 468.17M |
| June 18, 2026 | 402.61M |
| June 17, 2026 | 407.77M |
| June 16, 2026 | 357.71M |
| June 15, 2026 | 364.93M |
| June 12, 2026 | 343.77M |
| June 11, 2026 | 324.15M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 467.37B |
| Capricor Therapeutics, Inc. | 395.72M |
| Biogen, Inc. | 32.21B |
| Ardelyx, Inc. | 930.56M |
| Ocugen, Inc. | 462.80M |
Market Cap Related Metrics
| PS Ratio | 2.412 |
| PEG Ratio | -0.2301 |
| Price to Book Value | 6.083 |
| Price | 8.06 |
| Earnings Yield | -46.96% |
| PEGY Ratio | -0.2301 |